Clinical trial

Reconstruction of Monocytic Immunocompetence by Granulocyte-macrophage-colony…

NCT00252915 · Charite University, Berlin, Germany, Other · Completed

Key facts

NCT number NCT00252915
Title Reconstruction of Monocytic Immunocompetence by Granulocyte-macrophage-colony Stimulating Factor (GM-CSF) in Patients With Severe Sepsis and Septic Shock
Official title Reconstruction of Monocytic Immunocompetence by Granulocyte-macrophage-colony Stimulating Factor (GM-CSF) in Patients With Severe Sepsis and Septic Shock: a Prospective, Randomised, Double-blind, Placebo-controlled Study
Lead sponsor Charite University, Berlin, Germany, Other
Collaborators German Research Foundation
Status Completed
Phase Phase 2
Study type Interventional
Conditions Sepsis
Intervention type Biological
Interventions GM-CSF (verum)
Enrollment 38
Start date Nov 1, 2005
Primary completion Jan 1, 2007
Completion Apr 1, 2007
First posted Nov 15, 2005
Last update posted May 26, 2011

At a glance

  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies